Dr Russell received his medical training at Guy’s Hospital, London, UK, with further postgraduate training at St Bartholomew’s and St George’s Hospitals in London. He further specialized in respiratory medicine in the South East Thames Region and at the Royal Brompton Hospital, London. Dr Russell is a Consultant at Southern Health NHS Foundation Trust and is the Clinical Director of the West Hampshire Integrated Respiratory Service, looking after COPD and asthma for 2.5 million people. During his time at the Royal Brompton Hospital, he completed a PhD as a British Lung Foundation Research Fellow under the supervision of Professor Peter Barnes. The research focussed on the basic mechanisms of COPD and disease progression in a population of smokers in primary care, and this is as a Senior Clinical Researcher at the Nuffield Dept. of Medicine at the University of Oxford. He is the Clinical Director of the Respiratory Network of the Oxford Academic Health Science Network (AHSN).
Dr Russell has interests in obstructive lung disease, particularly pathophysiology of COPD and how patients should be cared for across the primary/secondary care interface. He has been a member of the British Thoracic Society (BTS) Executive, Scientific Committee and the Communications Committee, is active in the British Lung Foundation and was recently involved in drawing up the new asthma guidelines as part of the BTS/Scottish Intercollegiate Guidelines Network (SIGN) initiative. As founding editor of the International Journal of COPD (impact Factor 3.2, Dr Russell is keen to increase the awareness of COPD and provide a platform for advances in the understanding of COPD pathology, which are so desperately needed.
As well as being on the editorial board for Geriatric Medicine, Prescriber and The Lung Perspectives, Dr Russell is a peer reviewer for Thorax, American Journal of Respiratory and Critical Care Medicine, American Journal of Respiratory Cell and Molecular Biology, European Respiratory Journal, American Journal of Physiology and Journal of COPD. Dr Russell also writes and reviews for the Drug and Therapeutics Bulletin and contributes regularly to the BBC and other mainstream media as a spokesperson for the British Lung Foundation and BTS.